Dimensional Fund Advisors LP Sells 58,058 Shares of Cryolife Inc (NYSE:CRY)

Dimensional Fund Advisors LP lowered its position in shares of Cryolife Inc (NYSE:CRY) by 2.9% during the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 1,930,957 shares of the medical equipment provider’s stock after selling 58,058 shares during the quarter. Dimensional Fund Advisors LP owned 5.22% of Cryolife worth $54,800,000 as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors have also recently bought and sold shares of the business. United Services Automobile Association lifted its holdings in shares of Cryolife by 7.7% during the 4th quarter. United Services Automobile Association now owns 11,458 shares of the medical equipment provider’s stock worth $325,000 after acquiring an additional 822 shares during the last quarter. Thomson Horstmann & Bryant Inc. lifted its holdings in shares of Cryolife by 1.7% during the 4th quarter. Thomson Horstmann & Bryant Inc. now owns 297,852 shares of the medical equipment provider’s stock worth $8,453,000 after acquiring an additional 4,849 shares during the last quarter. Bessemer Group Inc. bought a new stake in shares of Cryolife during the 4th quarter worth $60,000. Great West Life Assurance Co. Can lifted its holdings in shares of Cryolife by 7.5% during the 4th quarter. Great West Life Assurance Co. Can now owns 43,728 shares of the medical equipment provider’s stock worth $1,144,000 after acquiring an additional 3,049 shares during the last quarter. Finally, Texas Permanent School Fund lifted its holdings in shares of Cryolife by 4.5% during the 4th quarter. Texas Permanent School Fund now owns 22,256 shares of the medical equipment provider’s stock worth $632,000 after acquiring an additional 968 shares during the last quarter. 71.34% of the stock is currently owned by hedge funds and other institutional investors.

A number of analysts have recently issued reports on CRY shares. ValuEngine raised shares of Cryolife from a “buy” rating to a “strong-buy” rating in a report on Wednesday, January 2nd. Zacks Investment Research downgraded shares of Cryolife from a “buy” rating to a “hold” rating in a report on Thursday, January 3rd. Northland Securities reissued a “buy” rating and issued a $32.00 price target on shares of Cryolife in a research note on Thursday, January 17th. Finally, Needham & Company LLC began coverage on shares of Cryolife in a research note on Wednesday, February 27th. They issued a “hold” rating and a $29.65 price target for the company. One analyst has rated the stock with a sell rating, one has given a hold rating, two have assigned a buy rating and one has assigned a strong buy rating to the company. The company has an average rating of “Buy” and an average price target of $32.16.

Cryolife stock traded down $0.22 during mid-day trading on Friday, hitting $27.55. The company’s stock had a trading volume of 225,366 shares, compared to its average volume of 230,493. The company has a quick ratio of 3.87, a current ratio of 5.19 and a debt-to-equity ratio of 0.81. The company has a market capitalization of $1.02 billion, a PE ratio of 105.96 and a beta of 0.54. Cryolife Inc has a 12 month low of $21.35 and a 12 month high of $36.05.

Cryolife (NYSE:CRY) last posted its quarterly earnings results on Wednesday, February 13th. The medical equipment provider reported $0.05 earnings per share for the quarter, missing the consensus estimate of $0.12 by ($0.07). The business had revenue of $67.80 million during the quarter, compared to the consensus estimate of $67.10 million. Cryolife had a positive return on equity of 3.49% and a negative net margin of 1.45%. As a group, equities analysts expect that Cryolife Inc will post 0.31 earnings per share for the current fiscal year.

In other news, Director Ronald D. Mccall sold 6,200 shares of the company’s stock in a transaction dated Thursday, February 21st. The shares were sold at an average price of $29.26, for a total transaction of $181,412.00. Following the completion of the transaction, the director now directly owns 137,699 shares of the company’s stock, valued at $4,029,072.74. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, VP Amy Horton sold 6,666 shares of the company’s stock in a transaction dated Wednesday, March 6th. The shares were sold at an average price of $29.15, for a total transaction of $194,313.90. Following the transaction, the vice president now directly owns 103,713 shares of the company’s stock, valued at $3,023,233.95. The disclosure for this sale can be found here. Insiders own 4.40% of the company’s stock.

COPYRIGHT VIOLATION WARNING: “Dimensional Fund Advisors LP Sells 58,058 Shares of Cryolife Inc (NYSE:CRY)” was originally posted by Baseball Daily News and is the property of of Baseball Daily News. If you are reading this report on another site, it was illegally stolen and republished in violation of United States & international copyright and trademark legislation. The original version of this report can be viewed at https://www.baseballdailydigest.com/news/2019/04/21/dimensional-fund-advisors-lp-has-54-80-million-position-in-cryolife-inc-cry.html.

Cryolife Company Profile

CryoLife, Inc, together with its subsidiaries, manufactures, processes, and distributes medical devices and implantable human tissues for use in cardiac and vascular surgeries worldwide. The company operates in two segments, Medical Devices and Preservation Services. It offers BioGlue, an agent for cross-linking proteins for cardiac, vascular, pulmonary, and general surgical applications; On-X mechanical heart valves for aortic and mitral indications; cardiac preservation services; PhotoFix, a bovine pericardial patch for use in cardiac and vascular repairing activities; and PerClot, an absorbable powdered hemostat for use in surgical procedures, including cardiac, vascular, orthopedic, neurological, gynecological, ENT, and trauma surgeries.

Featured Article: What is the QQQ ETF?

Institutional Ownership by Quarter for Cryolife (NYSE:CRY)

Receive News & Ratings for Cryolife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cryolife and related companies with MarketBeat.com's FREE daily email newsletter.